Influence of the rhenium-platinum system as nanolyposomes on the proliferative activity of cancer cells
Abstract
Decrease of proliferative activity of the cells of Guerin’s carcinoma T8 in the different conditions of administration of the Rhenium-Platinum anti-tumour system as nanolyposomes is shown. The Rhenium-Platinum anti-tumour system influenced on the morphological indices of tumour tissue. The cluster rhenium compounds reduced the indices of pathological mitoses 3.0–3.6 times in comparison with a control group. The amount of PCNA-positive cells under the Rhenium-Platinum system treatment went down by 82.5–84.5 %. The anti-tumour system led to the predominance of apoptotic cell death over the necrotic one. The most effective agent was the compound with cis-adamantan organic ligand cis-Re2(C10H15COO)2Cl4·2DMSO introducted on the 9th day.References
Аруин Л. И. Морфологическая диагностика болезней желудка и кишечника / Л. И. Аруин, Л. Л. Капуллер, В. А. Исаков. – М. : Триада-Х, 1998. – C. 13–26.
Жаврид Э. А. Гипертермия и гипергликемия в онкологии / Э. А. Жаврид, С. П. Осинский, С. З. Фрадкин. – К. : Наук. думка, 1987. – C. 45–58.
Липосомальные препараты: путь к преодолению лекарственной устойчивости к цисплатину / Г. И. Кулик, В. М. Пивнюк, М. М. Носко и др. // Онкология. – 2009. – Т. 11, № 1. – C. 76–80.
Лушников Е. Гибель клетки (апоптоз) / Е. Лушников, А. Ю. Абросимов. – М. : Медицина, 2001. – 192 с.
Онищенко Г. Е. Варианты программированной гибели клеток. – M. : МГУ им. М. В. Ломоносова, 2004. – 15 c.
Пушкарь С. Н. Возможность использования толерантных доз химиопрепаратов как радиомодификаторов, которые активируют церамидный путь апоптоза / С. Н. Пушкарь, Н. В. Белозор // Проблеми сучасної медичної науки та освіти. – 2009. – C. 54–57.
Руководство по иммуногистохимической диагностике опухолей человека / Под ред. С. В. Петрова, Н. Т. Райхлина. – Казань : Титул, 2004. – 456 с.
Тимофеевский А. Д. Модели и методы экспериментальной онкологии. – М. : Медгиз, 1960. – 268 c.
Хариет Э. Р. Иммуноцитохимия: электронная микроскопия / Э. Р. Хариет, К. С. Гаттер // Молекулярная клиническая диагностика. Методы / Под ред. С. Херрингтона, Д. Макги. – М. : Мир, 1999. – 558 с.
Beresford M. J. Measuring proliferation in breast cancer: practicalities and applications / M. J. Beresford, G. D. Wilson, A. Makris // Breast Cancer Research. – 2006. – Vol. 34. – P. 14–18.
Electron microscopy analysis of early localization of cisplatin in ovarian carcinoma cells / G. L. Beretta, S. C. Righetti, L. Lombardi et al. // Ultrastruct Pathol. – 2002. – Vol. 26. – P. 331–334. >>doi: 10.1080/01913120290104610
Chifotides H. T. Interactions of metal-metal-bonded antitumor active complexes with DNA fragments and DNA / H. T. Chifotides, K. R. Dunbar // Acc. Chem. Res. – 2005. – Vol. 38. – P. 146–156. >>doi: 10.1021/ar0302078
European convention for the protection of vertebrate animals used for experimental and other scientific purposes (ETS N 123). – Strasbourg. – 18.03.1986.
Platinum complexes with imino ethers or cyclic ligands mimicking imino ethers: Synthesis, in vitro antitumour activity, and DNA interaction properties / F. P. Intini, A. Boccarelli, V. C. Francia et al. // J. Biol. Inorg. Chem. – 2004. – Vol. 9. – P. 768–780. >>doi: 10.1007/s00775-004-0572-x
Activation of trans geometry in bifunctional mononuclear platinum complexes by a piperidine ligand – Mechanistic studies on antitumor action / J. Kasparkova, O. Novakova, V. Marini et al. // J. Biol. Chem. – 2003. – Vol. 278. – P. 47516–47525. >>doi: 10.1074/jbc.M304720200
Stem cells, senescence, neosis and self-renewal in cancer / R. Rajaraman, D. L. Guernsey, M. Rajaraman, S. R. Rajaraman // Cancer Cell International. – 2006. – Vol. 4. – P. 67–72. >>doi: 10.1186/1475-2867-6-25
Rosenberg B. Platinum complexes for the treatment of cancer: Why the search goes on in cisplatin. Chemistry and biochemistry of a leading anticancer drug / B. Rosenberg, B. Lippert // Wiley-VCH. – 1999. – Vol. 8. – P. 3–27.
Synthesis, characterization, in vivo antitumor properties of the cluster rhenium compound with GABA ligands and its synergism with cisplatin / A. Shtemenko, P. Collery, N. Shtemenko et al. // Dalton Trans. – 2009. – P. 5132–5136. >>doi: 10.1039/b821041a
Shtemenko A. V. Chemistry of binuclear rhenium clusters in rhenium and rhenium alloys / A. V. Shtemenko, B. A. Bovykin // TMS Publication, Pensilvania. – 1997. – P. 189–197.
Shtemenko N. I. Dichlorotetra-m-isobutiratodirhenium (III): Enhancement of cisplatin action and RBC-stabilizing properties / N. I. Shtemenko, P. Сollery, A. V. Shtemenko // Anticancer Research. – 2007. – Vol. 27, N 4. – P. 2487–2492.
Shtemenko N. The novel rhenium and platinum antitumor system / N. Shtemenko, P. Collery, A. Shtemenko // Journal of Biological Inorganic Chemistry. 13th International Conference on Biological Inorganic Chemistry. – Vienna, Austria, 2007. – Vol. 12. – P. 22. Wong E. Current status of platinum-based antitumor drugs / E. Wong, C. M. Giandomenico // Chem. Rev. – 1999. – Vol. 99. – P. 2451–2466.
Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons «Attribution» 4.0 License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.